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Biosensor: As a analytical device that can diagnose  the interest analyt 
in a sample and measure it quantitatily
Consisting of a biological recognition element and a physical 
transducer
3
 Introduction [1]
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4Biorecognition element: responsible to specific recognition of an 
analyte of interest
physical transducer: converts the biorecognition event into a 
measurable optical or electric signal
 With wide range of applications, such as: 
 Clinical diagnosis
 Environmental monitoring
 Food safety, drug discovery
 The first biosensor (glucose biosensor) invented by Clark and Lyons 
(1962) 
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 Introduction [1,2]
5 Nucleic acids
 Immunological molecules 
(natural or engineered) 
 Enzymes and nonenzymatic
receptors
 Microorganisms
Electrochemical
 Potentiometric
 Amperometric
 Conductometric
Optical
 Absorbance
 luminescence 
 Surface Plasmon resonance
 Refractive index
Piezoelectric
 Quartz crystal microbalance
 Surface acoustic wave
 Bulk acoustic wave
Physical transducer
Biological recognition 
element
Biosensor
[3]
Biosensor-based clinical diagnosis
 Biorecognition element immobilization techniques in 
biosensor [4]
 Microencapsulation
 Entrapment in gel
 Crosslinking
 Covalent immobilization
Physical adsorption
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 Biorecognition element immobilization techniques in 
biosensor [4]
1. Microencapsulation:
Use an ineffective membrane (cellulose acetate, polycarbonate, 
collagen)
2. Entrapment in gel:
The biological material mixture with a solution of monomers then 
monomers polymerized to becomes gel(Polyacrylamide)
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 Biorecognition element immobilization techniques in 
biosensor
3. Crosslinking:
Biological material bind to a solid carrier or materials such as gel 
connected (multifunctional material such as glutaraldehyde)
4. Physical adsorption:
Exploiting non-covalent interactions (hydrophobic forces,ionic binding
hydrogen bonding, and van der Waals interactions)
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 Biomolecule immobilization techniques in biosensor
5. Covalent immobilization:
Involves direct covalent binding (amine coupling and thiol coupling)
Use working surfaces:
Metals (gold, silver…) 
Carbonaceous surfaces (graphene, glassy carbon)
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 Biosensors classification [2,3]
 Depending on transducers nature
Electrochemical biosensors
piezoelectric biosensors
Optical biosensors
 Depending on recognition element
nature
 Immunosensor
 Nucleic acid-based biosensor 
 enzyme biosensors
 Aptasensor 
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Immunosensor: specific interaction of antibody with antigenic regions 
of an analyte (antibody as a biorecognition)
Nucleic acid-based biosensor : the hybridization of known molecular 
Nucleic acid probes or sequences with complementary strands in a test 
sample
Enzyme biosensors: relies upon a natural or fortuitous specificity of 
given enzymatic protein to react biochemically with a target substrate
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 Biosensors depending on recognition element nature [5]
 Aptasensors: biosensors that the biorecognation section 
consist of aptamer [6]
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Aptamer
Single-stranded synthetic (RNA or DNA) oligonucleotide 
Separation from aptamer libraries by SELEX Process
Formation different specific three-dimensional structures
Shape complementary binding to target
SELEX :systematic Evolution of Ligands by Exponential Enrichment 
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[7]
Biosensors depending on transducers nature
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 Electrochemical biosensors
[8]
Use electrode (gold , platinum, nickel ) as 
transducer
Enzyme electrochemical biosensors 
(oxidoreductase enzymes)
Affinity electrochemical biosensors 
(NA,Ab…) labeled by an enzyme 
(phosphatase, peroxidase)
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 Electrochemical biosensors
The biorecognition- analyt interaction cause change in
potential(potentiometric) or current(amperometric) on
electrode surface as output signal
As a function of, target analyte
type or concentration
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 Electrochemical biosensors [9]
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 Electrochemical biosensors
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 Piezoelectric biosensors 
[10,11]
An acoustic wave or piezoelectric biosensor utilizes acoustic or 
mechanical waves as a detection mechanism
Mass sensitive biosensors
Made with thin piece of piezoelectric crystals such as quartz, lithium 
niobate,or lithium tantalite(generate acoustic wave)
Consist of a parallel electrode (transducer) placed on both sides of the 
crystal
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 Piezoelectric biosensors
Piezoelectric effect: production of electrical charges by the 
imposition of mechanical stress
Converse effect: Applying an appropriate electrical field to a 
piezoelectric material creates a mechanical stress
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Applying electrical field
Excited acoustic waves
Mechanical oscillation of acoustic wave
Change in oscillation frequency by analyte binding
21
Electricaly measurement changes in mass ,elasticity, conductivity
in associate with Mass(analyt)attaches on crystal surface
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 Piezoelectric biosensors 
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 Piezoelectric biosensors [12]
Biosensor-based clinical diagnosis
23
 Piezoelectric biosensors
Biosensor-based clinical diagnosis
[12]
 Optical biosensors [2]
Based on the measure changes of the incident light ,arise the 
bioreceptor-target interaction
Measured changes in :
 Fluorescence 
Surface plasmon resonance or refractive index
Absorbance
• Use fiber optic as transduction element made of glass or plastic
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Optical biosensor
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Fluorescence: the process of light emission from excited 
species(Fluorophore) 
The fluorescent markers (coupled with bioreceptor) are excited 
by the incidental light from the evanescent wave
Fluorescent intensity , as a function of biosensor-target 
interaction as well as target molecule concentration
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 Fluorescence- based optical biosensors [14,15]
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 Fluorophores [14.15]
2. Molecular compound
• Organic compounds
Aromatic hydrocarbons (naphthalene, 
phenanthrene)
Amino acids (tryptophan, 
phenylalanine, tyrosine)
Fluorescein، rhodamine
• Inorganic compounds:
 Uranyl ion (UO2 +)
 Lanthanide ions (Tb3 + and Eu3 +)
• Organo-metallic Compounds
8-hydroxy quinoline
1. Nanomaterials
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Semiconductor quantum dots
Nanoscale metal clusters
Organo-mineral nanocomposites
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FRET : a nonradioactive energy transfer process between two 
Fluorophores(donor and acceptor) located in close proximity to each 
other
FRET-based biosensors genetically encoded
Performance in live cell
 Used to visualize activity of cellular signaling molecules such as:
 Ca2+, phospholipids
 Small GTPase, protein kinases
FRET: Fluorescence resonance energy transfer
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 FRET-based biosensors [16]
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 Main types of FRET fluorophores [17]
Quantum dots
 Fluorescent proteins (FPs)
 Cyan FP-yellow(CFP-YFP) Pairs 
 Green-red(GFP-RFP) FRET Pairs
 Far-red FPs (FFPs) and infrared fluorescent proteins (IFPs)
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 FRET biosensors efficiency determined by:
 Fluorophores distance ,orientation
 Proper spectral overlap of the donor emission 
and acceptor excitation, 
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 FRET efficiency measurement methods: [17]
1. Ratiometric analysis
Measure the acceptor/donor intensity ratio
2. lifetime analysis
Measure donor lifetime change
Two type of FRET biosensor:
30
Intermolecular biosensor
Intramolecular biosensor
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 Intermolecular biosensor [18]
 Donor and acceptor fluorophores fused to 
different molecules
 When two protein interact, bring the fluorophores 
into close proximity ,so increase the FRET 
efficiency
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 Intramolecular biosensor 
[19]
Donor and acceptor fluorophores conjoined to the same molecule
This type preferred because of :
High signal-to-noise ratio
Easy loading into the cells 
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 Intramolecular biosensor [19]
 Structure of an 
intramolecular FRET 
biosensor of small 
GTPase, Raichu
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 An aptamer-based biosensor for detection of thrombin 
using fluorescent quantum dots as labeling probes [20] 
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The procedure of aptamer-based single particle method for 
homogeneous detection of thrombin. QDs were linked with aptamer 
(TBA1 and TBA2) using EDC as coupling reagent (a). The QD-TBA 
probes reacted with the different concentrations of thrombin or 
human serum samples and formed the dimer (b).
The linear relationships between the logarithm 
of the characteristic diffusion time(log τD) of 
QDs and logarithm of thrombin 
concentration(log C) 
 An aptamer-based biosensor for detection of thrombin 
using fluorescent quantum dots as labeling probes [20]
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 Surface Plasmon resonance (SPR)-based optical biosensors
[3]
SPR: Collective oscillation of conduction electrons of in encounter 
with light
Plasmonic metal nanostructures as optical-signal transducer
Metals:
Silver, copper, aluminum , gold and etc.
Gold is preferred (chemical stability and free electron behavior)
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 Surface Plasmon resonance (SPR)-based optical biosensors
[3]
Transduction surface can be:
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Thin metal film
Metal nanoparticle
 Thin gold film SPR- biosensors [2]
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Is based on the interaction of light with a thin metallic film/solution 
dielectric interface
Light of a certain wavelength impinges at a specific angle (SPR angle)
Causing a minimum in reflected light intensity
( because of oscillations of mobile surface electrons)
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 Thin gold film SPR- biosensors [2]
Resonance angle is sensitive to refractive index
change ( caused by analyt binding)
Resonance angle shift (arise from refractive index change)
 provide information on the:
 Amount of bound analyte
Analyt –bioreceptor affinity
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 Thin gold film SPR- biosensors [21]
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 Thin gold film SPR- biosensors [21]
 Metal nanoparticle SPR-based biosensors [22]
Particles with dimensions 1-100 nm
In different forms of spherical , rod , triangular
Are widely used in diagnostic fields because of their advantages 
such as:
 High surface/volume ratio 
 Traceable physicochemical properties (related to their shape 
,size and compound )
 High stability
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 Nanoparticle SPR-based biosensors [22]
Gold nanoparticle with:
Strong absorption band in the visible region of the 
electromagnetic spectrum
Color change associated with the size and SPR
Provide visual colorimetric detection methods
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 Gold nanoparticle-DNA (AuNP-DNA) colorimetric [23]
Its based on the use of target DNA, complementary Gold 
nanoparticle-modified probe
Cross-linking (CL) method: using two type of nanoprobe
Non-Cross-linking (NCL) method: using one nanoprobe or 
interference of bare nanoparticle in presence probe
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 Direct detection of Escherichia coli genomic DNA using 
gold nanoprobes [24]
 Conclusion
Biosensors with: 
High sensitivity and specificity, of nanoscale size 
Cost-effective
Using a small volume 
Continuous measurement
High speed and
Can be replaced with  time-consuming and costly conventional methods
to clinical diagnosis
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